Supply Chain Integrity Featured Articles
-
Clinical News Roundup: Artificial Intelligence Ready To Run Clinical Trials
11/11/2016
Clinical News Roundup for the week of November 7, 2016 with information on artificial intelligence running clinical trials, the UPS acquisition of Marken, efforts to track unpublished trial data, clinical success with the Zika virus, Takeda’s digital health efforts, and more.
-
UPS Expands Clinical Life Science Opportunities With Marken Acquisition
11/7/2016
UPS has entered into a definitive purchase agreement to acquire Marken, a global, privately-held provider of supply chain solutions to the life sciences industry. The transaction, which provides UPS with growth opportunities across the life sciences customer base, is expected to close by December 31, 2016, subject to customary conditions and regulatory approvals.
-
CROs Can Be Indispensable As Pharma Companies Focus On Value
9/15/2016
The healthcare industry’s transition to value-based care is putting a lot of pressure on pharmaceutical companies in terms of margins and the need to demonstrate improved outcomes at lower costs. In attempting to create breakthrough therapies and “beyond the pill” solutions with fewer resources, companies are demonstrating an increased appetite for outsourcing functions – and Contract Research Organizations (CROs) could be the beneficiaries.
-
Phase I Clinical Supply Landscape: Trends, Demarcation And Security
8/30/2016
The core addressable early phase market is USD 11.9 billion growing with a CAGR of 2 – 3 percent. Early-phase trials are outsourced at greater than 60 percent by pharma, as the trials are costly and small in number. The supply market for early phase is comprised by CROs, research centers, and academic institutes. The market size that is comprised by the CROs is estimated to be around USD 8 billion, which is about 67 percent of the early phase market.
-
Overcome The Increasing Complexity Of Clinical Logistics
8/24/2016
Clinical trials have become more complex than ever. Although there is still some debate around exactly how complex they have become, trials today seem to have more endpoints, procedures, eligibility criteria, protocol amendments, and investigator sites than just 10 years ago. Add adaptive trials to the mix, and clinical supply executives have more to worry about than ever before. Perhaps it’s time to make your clinical supply chain as flexible as your trials.
-
Clinical Trials: A Winning Step Toward Medical Breakthroughs
7/25/2016
There is a direct correlation between innovations in modern medicine and clinical trials. Researchers and their sponsors continue to push what is possible with new forms of life-saving therapies enabled through cutting-edge science and good, old-fashioned trial and error. Modern medicines improve quality of lives. Clinical trials improve the quality of modern medicines.
-
Clinical News Roundup: Should You Be Concerned About For-Profit Review Boards?
7/8/2016
Clinical News Roundup for the week of July 4, 2016 featuring for-profit institutional review boards, inefficiencies in clinical trials, smarter approaches to oncology trial design, clinical trial logistics, and integration between ClinicalTrials.gov and Drugs@FDA.
-
New Coordination Hub And Distribution Center Serves Pharma’s Clinical Supply Needs
4/11/2016
In clinical trials, many functions have to operate smoothly and efficiently for an approval to be granted. With all of the attention being paid to patients, data, innovation, and new technologies, one aspect that can get overlooked is the packaging, labeling, and distribution of clinical supplies. No trial can take place unless sites – and ultimately patients – receive their required clinical supplies.
-
As Chiltern Acquires Theorem, Study Continuity Remains The Central Priority
8/7/2015
Global CRO Chiltern has announced it will acquire Theorem Clinical Research, another global contract research firm. The company has signed a purchase agreement for the acquisition. According to Chiltern CEO Jim Esinhart, the move was made in response to client demand for a CRO partner that could provide scientific and operating strengths across the globe, but do so in a responsive and flexible way. The acquisition will bring together 3,700 employees of the two CROs working in more than 45 countries. The combined company will adhere to a stated philosophy of clinical trials “Designed Around you.”
-
Should You Outsource Your Pharma Supply Chain?
6/11/2015
Have you thought about taking the bold step of outsourcing some or all of your pharma supply chain? If so, you won’t be the first company to consider it. But is outsourcing the best option?